ATE135408T1 - Für ein protein mit der fähigkeit zur zusammenwirkung mit dem enhancer des alpha- fetoproteingens kodierende dna - Google Patents

Für ein protein mit der fähigkeit zur zusammenwirkung mit dem enhancer des alpha- fetoproteingens kodierende dna

Info

Publication number
ATE135408T1
ATE135408T1 AT90906374T AT90906374T ATE135408T1 AT E135408 T1 ATE135408 T1 AT E135408T1 AT 90906374 T AT90906374 T AT 90906374T AT 90906374 T AT90906374 T AT 90906374T AT E135408 T1 ATE135408 T1 AT E135408T1
Authority
AT
Austria
Prior art keywords
protein
alpha
enhancer
interact
ability
Prior art date
Application number
AT90906374T
Other languages
English (en)
Inventor
Tomonori Morinaga
Hisataka Yasuda
Kanji Higashio
Taiki Tamaoki
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Application granted granted Critical
Publication of ATE135408T1 publication Critical patent/ATE135408T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT90906374T 1989-05-01 1990-04-27 Für ein protein mit der fähigkeit zur zusammenwirkung mit dem enhancer des alpha- fetoproteingens kodierende dna ATE135408T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1112519A JP2686819B2 (ja) 1989-05-01 1989-05-01 α―フェトプロテイン遺伝子のエンハンサーに結合する蛋白質をコードするＤＮＡ

Publications (1)

Publication Number Publication Date
ATE135408T1 true ATE135408T1 (de) 1996-03-15

Family

ID=14588679

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90906374T ATE135408T1 (de) 1989-05-01 1990-04-27 Für ein protein mit der fähigkeit zur zusammenwirkung mit dem enhancer des alpha- fetoproteingens kodierende dna

Country Status (10)

Country Link
US (1) US5302698A (de)
EP (1) EP0427863B1 (de)
JP (1) JP2686819B2 (de)
AT (1) ATE135408T1 (de)
AU (1) AU630189B2 (de)
CA (1) CA2032167C (de)
DE (1) DE69025856T2 (de)
DK (1) DK0427863T3 (de)
ES (1) ES2086402T3 (de)
WO (1) WO1990013655A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0673457B2 (ja) * 1990-11-07 1994-09-21 雪印乳業株式会社 α―フェトプロティン遺伝子のエンハンサーに結合する蛋白質をコードするＤＮＡ
US5965528A (en) 1991-09-27 1999-10-12 Mcgill University Recombinant human alph-fetoprotein as an immunosuppressive agent
US6288034B1 (en) * 1995-01-24 2001-09-11 Martinex R & D Inc. Recombinant human alpha-fetoprotein as an immunosuppressive agent
US6268212B1 (en) * 1993-10-18 2001-07-31 Amgen Inc. Tissue specific transgene expression
US6676935B2 (en) 1995-06-27 2004-01-13 Cell Genesys, Inc. Tissue specific adenoviral vectors
US6254862B1 (en) 1997-03-03 2001-07-03 Calydon, Inc. Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof
US20020068049A1 (en) * 1998-09-10 2002-06-06 Henderson Daniel R. Tissue specific adenoviral vectors
US7011976B1 (en) 1997-03-03 2006-03-14 Calydon, Inc. Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof
US7208576B2 (en) 1999-01-06 2007-04-24 Merrimack Pharmaceuticals, Inc. Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof
US6911200B2 (en) * 2000-03-24 2005-06-28 Cell Genesys, Inc. Methods of treating neoplasia with combination of target-cell specific adenovirus, chemotherapy and radiation
US20100304873A1 (en) * 2009-05-28 2010-12-02 Lipa Markowitz Bowling Ball and Football Game Controller

Also Published As

Publication number Publication date
DK0427863T3 (da) 1996-07-29
DE69025856T2 (de) 1996-08-01
CA2032167A1 (en) 1990-11-02
WO1990013655A1 (fr) 1990-11-15
EP0427863A4 (en) 1992-05-13
AU5520390A (en) 1990-11-29
US5302698A (en) 1994-04-12
DE69025856D1 (de) 1996-04-18
JP2686819B2 (ja) 1997-12-08
AU630189B2 (en) 1992-10-22
EP0427863A1 (de) 1991-05-22
CA2032167C (en) 1998-08-18
ES2086402T3 (es) 1996-07-01
JPH02291267A (ja) 1990-12-03
EP0427863B1 (de) 1996-03-13

Similar Documents

Publication Publication Date Title
ATE182901T1 (de) Für androgen-rezeptor-protein kodierende dna
FI101720B1 (fi) Synteettisen DNA:n konstruointi ja sen käyttö suurten polypeptidien synteesissä
DE68925083D1 (de) Rekombinante DNS, diese rekombinante DNS enthaltender Mikroorganismus und Verfahren zur Herstellung von L-Aminosäure unter Verwendung dieses Mikroorganismus
ES8800266A1 (es) Un metodo para obtener un polipeptido complementario de al menos una porcion de un peptido o proteina original
ATE135408T1 (de) Für ein protein mit der fähigkeit zur zusammenwirkung mit dem enhancer des alpha- fetoproteingens kodierende dna
ATE90944T1 (de) Fuer ein hirudinaehnliches protein kodierende dns- sequenz und verfahren zur herstellung eines solchen proteins.
ATE92105T1 (de) Expression von faktor-vii-aktivitaet in saeugetierzellen.
ES2054601T3 (es) Proteina con actividad de tipo citoquina, adn recombinante codante para esta proteina, celulas y microorganismos transformados.
DK0477971T3 (da) Humant CNP gen og precursorprotein
DE68914664D1 (de) Gereinigte ubiquitin-hydrolase, diese kodierende dns-sequenzen und ihre verwendung zur gewinnung von polypeptiden.
NO892033D0 (no) Fibronectinbindende protein.
JPS6485096A (en) Hybrid human protein c and biotechnological synthesis thereof
ZA861482B (en) Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known
ATE152481T1 (de) Neue polypeptide, dna-sequenzen, die deren expression erlauben, verfahren zur vorbereitung und verwendung
SE8702272L (sv) Fibronektinbindande protein samt dess framstaellning
DE69332148D1 (de) Verwendung einer dna sequenz, kodierende für ein protein mit der fäligkeit oxalsäure abzubauen, zur genselektion
ES2083352T3 (es) Produccion de proteinas activas que contienen residuos de cisteina.
DE3583267D1 (de) Druckmaterialsatz zur herstellung von barkodeetiketten.
PT676413E (pt) Proteina de ligacao a interferoes alfa/beta, sua preparacao e utilizacao
DK0487229T3 (da) DNA, der koder for et protein, som binder til enhanceren for alfa-føtoproteingenet
DE69213145D1 (de) Verfahren zur expression von polypeptiden
ATE104344T1 (de) Gereinigte ubiquitin-hydrolase, diese kodierende dns-sequenzen und ihre verwendung zur gewinnung von polypeptiden.
ATE95238T1 (de) Leader-anteile zur produktion von rekombinanten proteinen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee